Clinical Trials

MD Anderson Launches Institute for Pioneering Cell Therapy Research
Research & Development MD Anderson Launches Institute for Pioneering Cell Therapy Research

The University of Texas MD Anderson Cancer Center has unveiled its ambitious new initiative, the Institute for Cell Therapy Discovery & Innovation, fueled by an impressive initial funding of over $80 million. This pioneering institute aims to revolutionize the realms of immunology and cell

Global Cell Culture Vessels Market to Reach $19.65B by 2033
Management & Regulatory Global Cell Culture Vessels Market to Reach $19.65B by 2033

The global cell culture vessels market is on a remarkable growth trajectory, projected to expand from an estimated USD 4.90 billion in 2023 to over USD 19.65 billion by 2033. This significant growth, at a robust CAGR of 14.9% from 2024 to 2033, underscores the critical role of cell culture

Rising Breast Cancer Rates Among Indian Women Aged 55-64 Demand Action
Research & Development Rising Breast Cancer Rates Among Indian Women Aged 55-64 Demand Action

Breast Cancer Awareness Month has highlighted a pressing health crisis among Indian women, particularly those aged 55 to 64. A recent report by Healthians reveals that 16% of women in this demographic are affected by breast cancer. This alarming statistic underscores the urgent need for awareness,

AbbVie Faces Setback as Schizophrenia Drug Fails Clinical Trials
Research & Development AbbVie Faces Setback as Schizophrenia Drug Fails Clinical Trials

The pharmaceutical industry is no stranger to challenges and setbacks, especially in the area of neurological and psychiatric treatments. AbbVie, a multinational biopharmaceutical company, recently faced a significant hurdle when its promising schizophrenia drug, emraclidine, failed to meet

Gene Therapy Investment Falls Post-COVID, Showing Future Hope
Management & Regulatory Gene Therapy Investment Falls Post-COVID, Showing Future Hope

The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising

Trump's Return Sparks Uncertainty for Biopharma and Vaccine Sector
Research & Development Trump's Return Sparks Uncertainty for Biopharma and Vaccine Sector

The election of Donald Trump and his return to the White House have sparked significant discussions about the potential impacts on various sectors, particularly the biopharma and vaccine industries. With anticipated shifts in federal policies and key personnel appointments, stakeholders are keenly

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later